Test atropine eye drops to slow worsening nearsightedness in kids
Part of Eyes & vision clinical trials.
This Phase 3 trial tests different doses of atropine eye drops to see which dose best slows myopia (nearsightedness) from getting worse in children. It may help by reducing how fast your child’s eyesight changes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is age 6 to 11 and has myopia in both eyes (bilateral myopia).
- Myopia started when your child was at least 4 years old, and it has been getting worse before.
- Your child’s nearsightedness measurement is between -1.00 and -6.00 (in each eye) based on a cyclops-free (numbed) eye measurement.
- Eye pressure is under 21 mm Hg in each eye (checked at screening).
- Your child can see clearly enough with glasses for each eye to meet the trial’s distance-vision test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether daily atropine eye drops can slow down worsening nearsightedness in children. It's for kids aged 5–10 whose myopia is actively progressing.
This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.
This study tests whether atropine eye drops can slow down worsening nearsightedness in children. It is for children whose nearsightedness is getting worse quickly and who have not tried other treatments.
This trial tests whether atropine eye drops can slow down worsening nearsightedness (myopia) in children and teenagers. It may help keep their eyesight from getting worse over time.
This study tests whether a very low-dose atropine eye drop (0.01%) can safely slow down worsening nearsightedness in children. It is for kids ages 3 to 12 who are already nearsighted but haven't used other myopia control treatments before.
This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.
Hear when a new Progressive Myopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.